Department of Microbiology and Immunology, University at Buffalo School of Medicine, Buffalo, New York, USA.
Department of Microbiology and Immunology, University at Buffalo School of Medicine, Buffalo, New York, USA
Infect Immun. 2021 Mar 17;89(4). doi: 10.1128/IAI.00653-20.
Elderly individuals are at increased risk of life-threatening pulmonary infections. Neutrophils are a key determinant of the disease course of pathogen-induced pneumonia. Optimal host defense balances initial robust pulmonary neutrophil responses to control pathogen numbers, ultimately followed by the resolution of inflammation to prevent pulmonary damage. Recent evidence suggests that phenotypic and functional heterogeneity in neutrophils impacts host resistance to pulmonary pathogens. Apart from their apparent role in innate immunity, neutrophils also orchestrate subsequent adaptive immune responses during infection. Thus, the outcome of pulmonary infections can be shaped by neutrophils. This review summarizes the age-driven impairment of neutrophil responses and the contribution of these cells to the susceptibility of the elderly to pneumonia. We describe how aging is accompanied by changes in neutrophil recruitment, resolution, and function. We discuss how systemic and local changes alter the neutrophil phenotype in aged hosts. We highlight the gap in knowledge of whether these changes in neutrophils also contribute to the decline in adaptive immunity seen with age. We further detail the factors that drive dysregulated neutrophil responses in the elderly and the pathways that may be targeted to rebalance neutrophil activity and boost host resistance to pulmonary infections.
老年人患危及生命的肺部感染的风险增加。中性粒细胞是病原体诱导性肺炎疾病进程的关键决定因素。最佳的宿主防御平衡了初始强烈的肺部中性粒细胞反应,以控制病原体数量,最终炎症得到解决,以防止肺部损伤。最近的证据表明,中性粒细胞的表型和功能异质性影响宿主对肺部病原体的抵抗力。除了它们在先天免疫中的明显作用外,中性粒细胞在感染期间还协调随后的适应性免疫反应。因此,肺部感染的结果可以由中性粒细胞决定。这篇综述总结了年龄导致的中性粒细胞反应受损以及这些细胞对老年人易患肺炎的贡献。我们描述了衰老如何伴随着中性粒细胞募集、解决和功能的变化。我们讨论了全身和局部变化如何改变老年宿主中性粒细胞的表型。我们强调了一个知识空白,即这些中性粒细胞的变化是否也有助于随着年龄增长而出现的适应性免疫下降。我们进一步详细介绍了导致老年人中性粒细胞反应失调的因素,以及可能用于重新平衡中性粒细胞活性并增强宿主对肺部感染抵抗力的途径。